Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours Β· Estimated delivery Oct 6 - Oct 11
About Enicepatide (CT-388) Enicepatide is an investigational once-weekly subcutaneous injectable, dual GLP-1/GIP receptor agonist being developed for the treatment of people living with obesity and associated comorbidities including type 2 diabetes (T2D)
A: You can incorporate collagen through supplements, such as our Collagen Peptides, bone broth, or collagen-infused hair products
[Accessed 5 September 2025]
Thyroid conditions : Generally safe in treated hypothyroidism, but not suitable for patients with a history of thyroid cancer (MTC or MEN2)
US$ 23.76
US$ 28.68
US$ 26.43
US$ 25.15
US$ 23.53
US$ 25.40
US$ 27.16
US$ 23.45
US$ 22.37
US$ 29.87
US$ 23.19
